| Ms Pamela R Coleman, | |
|
1 Cooper Plz, Camden, NJ 08103-1461 | |
| (856) 342-2000 | |
| Not Available |
| Full Name | Ms Pamela R Coleman |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Adult Health |
| Location | 1 Cooper Plz, Camden, New Jersey |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942911979 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2086S0127X | Surgery - Trauma Surgery | 26NJ01403600 (New Jersey) | Secondary |
| 363LA2200X | Nurse Practitioner - Adult Health | 26NR16289500 (New Jersey) | Primary |
| Entity Name | Cooper University Trauma Physicians, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790724730 PECOS PAC ID: 3678569951 Enrollment ID: O20040422000430 |
News Archive
Rice University chemists have discovered a way to load dozens of molecules of the anti-cancer drug paclitaxel onto tiny gold spheres. The result is a tiny ball, many times smaller than a living cell that literally bristles with the drug.
Today the National Academy of Sciences announced a three-year, $271,930 grant to chemist Vincent Rotello at the University of Massachusetts Amherst to develop, test and deploy new, sensitive, reliable and affordable inkjet-printed, nanoparticle-based test strips for detecting disease-causing bacteria in drinking water, with researchers at the Lahore University of Management Sciences (LUMS), Pakistan.
In an effort to sidestep the ethical dilemma involved in using human embryonic stem cells to treat diseases, scientists are developing non-controversial alternatives: In particular, they are looking for drug-like chemical compounds that can transform adult skin cells into the stem cells now obtained from human embryos. That's the topic of a fascinating article in Chemical & Engineering News (C&EN), ACS' weekly newsmagazine.
A new guide on pancreatic cancer, co-authored by the chair of Surgery at Thomas Jefferson University Hospital, offers a better understanding to patients and caregivers of the unique challenges associated with a diagnosis of pancreatic cancer.
Taiga Biotechnologies, Inc. today announced that the company has received three new Small Business Innovation Research (SBIR) grants from the National Institutes of Health, totaling $1.7 million. This adds to the two previous grants awarded to Taiga for various applications of its proprietary technology platforms, for a total in NIH funding to date of over $2.1 million.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Pamela R Coleman, 1 Federal St Ste 200, Camden, NJ 08103-1088 Ph: (848) 288-6935 | Ms Pamela R Coleman, 1 Cooper Plz, Camden, NJ 08103-1461 Ph: (856) 342-2000 |
News Archive
Rice University chemists have discovered a way to load dozens of molecules of the anti-cancer drug paclitaxel onto tiny gold spheres. The result is a tiny ball, many times smaller than a living cell that literally bristles with the drug.
Today the National Academy of Sciences announced a three-year, $271,930 grant to chemist Vincent Rotello at the University of Massachusetts Amherst to develop, test and deploy new, sensitive, reliable and affordable inkjet-printed, nanoparticle-based test strips for detecting disease-causing bacteria in drinking water, with researchers at the Lahore University of Management Sciences (LUMS), Pakistan.
In an effort to sidestep the ethical dilemma involved in using human embryonic stem cells to treat diseases, scientists are developing non-controversial alternatives: In particular, they are looking for drug-like chemical compounds that can transform adult skin cells into the stem cells now obtained from human embryos. That's the topic of a fascinating article in Chemical & Engineering News (C&EN), ACS' weekly newsmagazine.
A new guide on pancreatic cancer, co-authored by the chair of Surgery at Thomas Jefferson University Hospital, offers a better understanding to patients and caregivers of the unique challenges associated with a diagnosis of pancreatic cancer.
Taiga Biotechnologies, Inc. today announced that the company has received three new Small Business Innovation Research (SBIR) grants from the National Institutes of Health, totaling $1.7 million. This adds to the two previous grants awarded to Taiga for various applications of its proprietary technology platforms, for a total in NIH funding to date of over $2.1 million.
› Verified 2 days ago